Intraventricular infusion of nerve growth factor as the cause of sympathetic fiber sprouting in sensory ganglia

Journal of Neurosurgery

Volumn 91, Issue 3, 1999, Pages 447-453

  Nauta, Haring J W ^b   Wehman, Joseph C ^b   Koliatsos, Vassilis E ^b   Terrell, Marylee A ^b   Chung, Kyungsoon ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b NONE

Author keywords

Alzheimer's disease; Nerve growth factor; Pain; Therapy

Indexed keywords

RECOMBINANT NERVE GROWTH FACTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACKACHE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; IMMUNOHISTOCHEMISTRY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LUMBAR SPINE; MALE; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY GANGLION; SPINAL GANGLION; SYMPATHETIC NERVE; WEIGHT REDUCTION;

EID: 0032809057     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1999.91.3.0447     Document Type: Article

References (46)

1. Arnér S: Intravenous phentolamine test: diagnostic and prognostic use in reflex sympathetic dystrophy. Pain 46:17-22, 1991
2. Bennett GJ, Xie YK: An experimental peripheral neuropathy in rat that produces abnormal pain sensation, in Dubner R, Gebhart GF, Bond MR (eds): Proceedings of the Vth World Congress on Pain. Pain Research and Clinical Management, Vol 3. Amsterdam: Elsevier, 1988, pp 129-134
3. Chung K, Kim HJ, Na HS, et al: Abnormalities of sympathetic innervation in the area of an injured peripheral nerve in a rat model of neuropathic pain. Neurosci Lett 162:85-88, 1993
4. Chung K, Lee BH, Yoon YW, et al: Sympathetic sprouting in the dorsal root ganglia of the injured peripheral nerve in a rat neuropathic pain model. J Comp Neurol 376:241-252, 1996
5. Davis BM, Albers KM, Seroogy KB, et al: Overexpression of nerve growth factor in transgenic mice induces novel sympathetic projections to primary sensory neurons. J Comp Neurol 349:464-474, 1994
6. Davis KD, Treede RD, Raja SN, et al: Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain 47:309-317, 1991
7. Fischer W, Wictorin K, Björklund A, et al: Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329:65-68, 1987
8. Gonzales R, Sherbourne CD, Goldyne ME, et al: Noradrenaline-induced prostaglandin production by sympathetic postganglionic neurons is mediated by α2-adrenergic receptors. J Neurochem 57:1145-1150, 1991
9. Hefti F: Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 6: 2155-2162, 1986
10. Hefti F, Hartikka J, Eckenstein F, et al: Nerve growth factor increases choline acetyltransferase but not survival or fiber outgrowth of cultured fetal septal cholinergic neurons. Neuroscience 14:55-68, 1985
11. Hefti F, Will B: Nerve growth factor is a neurotrophic factor for forebrain cholinergic neurons: implications for Alzheimer's disease. J Neural Transm Park Dis Dement Sect 24: 309-315, 1987
12. Hoffert MJ, Greenberg RP, Wolskee PJ, et al: Abnormal and collateral innervations of sympathetic and peripheral sensory fields associated with a case of causalgia. Pain 20:1-12, 1984
13. Isaacson LG, Saffran BN, Crutcher KA: Nerve growth factor-induced sprouting of mature, uninjured sympathetic axons. J Comp Neurol 326:327-336, 1992
14. Kim SH, Chung JM: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50:355-363, 1992
15. Kim SH, Chung JM: Sympathectomy alleviates mechanical allodynia in an experimental animal model for neuropathy in the rat. Neurosci Lett 134:131-134, 1991
16. Koliatsos VE: Biological therapies for Alzheimer's disease: focus on trophic factors. Crit Rev Neurobiol 10:205-238, 1996
17. Koliatsos VE, Applegate MD, Knüsel B, et al: Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat. Exp Neurol 112:161-173, 1991
18. Kromer LF: Nerve growth factor treatment after brain injury prevents neuronal death. Science 235:214-216, 1987
19. Levine JD, Taiwo YO, Collins SD, et al: Noradrenaline hyperalgesia is mediated through interaction with sympathetic postganglionic neurone terminals rather than activation of primary afferent nociceptors. Nature 323:158-160, 1986
20. Lewin GR, Ritter AM, Mendell LM: Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 13: 2136-2148, 1993
21. Lewin GR, Rueff A, Mendell LM: Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci 6: 1903-1912, 1994
22. Lindvall O, Backlund EO, Farde L, et al: Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol 22:457-468, 1987
23. Loh L, Nathan PW, Schott GD, et al: Effects of regional guanethidine infusion in certain painful states. J Neurol Neurosurg Psychiatry 43:446-451, 1980
24. McLachlan EM, Jänig W, Devor M, et al: Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia. Nature 363:543-546, 1993
25. Neil A, Attal N, Guilbaud G: Effects of guanethidine on sensitization to natural stimuli and self-mutilating behaviour in rats with a peripheral neuropathy. Brain Res 565:237-246, 1991
26. Neumann S, Doubell TP, Leslie T, et al: Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 384:360-364, 1996
27. Nordberg A, Almkvist O, Amberla K, et al: Responders and non-responders to tacrine, ondansetron and NGF treatment in Alzheimer patients as evaluated by positron emission tomography and APOE genotype, in Iqbal K, Winblad B, Nishimura T, et al (eds): Alzheimer's Disease: Biology, Diagnosis and Therapeutics. Chichester: John Wiley & Sons, 1997, pp 647-654
28. Olson L: NGF and the treatment of Alzheimer's disease. Exp Neurol 124:5-15, 1993
29. Olson L, Backlund EO, Ebendal T, et al: Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial. Arch Neurol 48:373-381, 1991
30. 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J Neural Transm Park Dis Dement Sect 4:79-95, 1992
31. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 2. San Diego: Academic Press, 1986
32. Phelps CH, Gage FH, Growdon JH, et al: Potential use of nerve growth factor to treat Alzheimer's disease. Neurobiol Aging 10:205-207, 1989
33. Purves D, Snider WD, Voyvodic JT: Trophic regulation of nerve cell morphology and innervation in the autonomic nervous system. Nature 336:123-128, 1988
34. Raja SN, Treede RD, Davis KD, et al: Systemic alpha-adrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain. Anesthesiology 74:691-698, 1991
35. Ramer MS, Bisby MA: Rapid sprouting of sympathetic axons in dorsal root ganglia of rats with a chronic constriction injury. Pain 70:237-244, 1997
36. Ruit KG, Osborne PA, Schmidt RE, et al: Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse. J Neurosci 10:2412-2419, 1990
37. Saffran BN, Woo JE, Mobley WC, et al: Intraventricular NGF infusion in the mature rat brain enhances sympathetic innervation of cerebrovascular targets but fails to elicit sympathetic ingrowth. Brain Res 492:245-254, 1989
38. Sebert ME, Shooter EM: Expression of mRNA for neurotrophic factors and their receptors in the rat dorsal root ganglion and sciatic nerve following nerve injury. J Neurosci Res 36: 357-367, 1993
39. Seltzer Z, Dubner R, Shir Y: A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43:205-218, 1990
40. Shen H, Chung JM, Chung K: Expression of neurotrophin mRNAs in the dorsal root ganglion after spinal nerve injury. Mol Brain Res 64:186-192, 1999
41. Shir Y, Seltzer Z: Effects of sympathectomy in a model of causalgiform pain produced by partial sciatic nerve injury in rats. Pain 45:309-320, 1991
42. Wahren LK, Torebjörk E, Nyström B: Quantitative sensory testing before and after regional guanethidine block in patients with neuralgia in the hand. Pain 46:23-30, 1991
43. Wilcock GK, Esiri MM, Bowen DM, et al: The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry. Neuropathol Appl Neurobiol 9:175-179, 1983
44. Williams LR, Varon S, Peterson GM, et al: Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci USA 83: 9231-9235, 1986
45. Winkler J, Ramirez GA, Kuhn G, et al: Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neuntes after intraventricular administration of nerve growth factor. Ann Neurol 41:82-93, 1997
46. Woolf CJ, Ma QP, Allchorne A, et al: Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J Neurosci 16:2716-2723, 1996